230 related articles for article (PubMed ID: 395072)
1. Use of an artificial beta cell in surgery.
Horwitz DL; Schwartz SS
Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
[TBL] [Abstract][Full Text] [Related]
2. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
[No Abstract] [Full Text] [Related]
3. Therapeutical application of artificial beta-cell in surgery and obstetrics.
Brunetti P; Puxeddu A; Calabrese G; Massi-Benedetti M; Santeusanio F; Bolli G; Scionti L; Bueti A; Angeletti G
Horm Metab Res Suppl; 1979; (8):162-5. PubMed ID: 395074
[TBL] [Abstract][Full Text] [Related]
4. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
Lambert AE; Buysschaert M; Lambotte L
Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
[No Abstract] [Full Text] [Related]
5. Control algorithms for artificial beta cell.
Clemens AH
Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
[TBL] [Abstract][Full Text] [Related]
6. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
Beyer J; Wolf E; Cordes U; Hassingen W
Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
[TBL] [Abstract][Full Text] [Related]
7. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
Kerner W; Beischer W; Herfarth C; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
[TBL] [Abstract][Full Text] [Related]
8. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
9. Development of a closed-loop artificial pancreas.
Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
[TBL] [Abstract][Full Text] [Related]
10. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
11. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
Pfeiffer EF; Thum C; Clemens AH
Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
[No Abstract] [Full Text] [Related]
12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
Stavljenić A; Granić M; Topić B; Skrabalo Z
Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
[TBL] [Abstract][Full Text] [Related]
14. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
[TBL] [Abstract][Full Text] [Related]
15. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
16. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
Froesch ER; Blatter G; Morell B
Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
[TBL] [Abstract][Full Text] [Related]
17. The use of artificial beta cell in diagnosis and treatment of insulinoma.
Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
[TBL] [Abstract][Full Text] [Related]
18. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
[TBL] [Abstract][Full Text] [Related]
19. Computer-controlled bedside monitoring and infusion system.
Sailer D; Berg G
Horm Metab Res Suppl; 1979; (8):45-8. PubMed ID: 43830
[TBL] [Abstract][Full Text] [Related]
20. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
Brunetti P; Massi-Benedetti M; Puxeddu A; Santeusanio F; Calabrese G; Bolli G; Scionti L; Angeletti G
Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
